GW Pharmaceuticals Q2 Results Crush Revenue Estimates; Stock Soars
Shares of GW Pharmaceuticals (NASDAQ: GWPH) surged in after-market trading Tuesday. This was on the back of the company's fiscal 2019 second-quarter results, which were released after market close.
As with other marijuana stocks lately, GW Pharmaceuticals posted immense growth on the top line. The quarter's revenue came in at just over $72 million, far above the $3.3 million in the same period last year. This result easily surpassed the average analyst expectation of $47 million.
Image source: Getty Images.
Quelle Fool.com
